Does Tolterodine Extended Release Affect the Bladder Electrical Perception Threshold? A Placebo Controlled, Double-Blind Study With 4 and 8 mg in Healthy Volunteers

Journal of Urology

Volumn 178, Issue 6, 2007, Pages 2495-2500

  Mehnert, Ulrich ^a   Reitz, André ^a   Ziegler, Maya ^a   Knapp, Peter A ^a   Schurch, Brigitte ^a  

^a BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

bladder; electrical stimulation; sensory thresholds; tolterodine; urinary incontinence

Indexed keywords

PLACEBO; TOLTERODINE;

ADULT; ARTICLE; BLADDER FUNCTION; BLADDER NECK; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG RELEASE; ELECTROSTIMULATION; FATIGUE; FEMALE; HEADACHE; HUMAN; MICTURITION; NAUSEA; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION; VOMITING;

ADMINISTRATION, ORAL; ADULT; BENZHYDRYL COMPOUNDS; CRESOLS; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION; FEMALE; HUMANS; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SENSORY THRESHOLDS; URINARY BLADDER; URINARY CATHETERIZATION; URODYNAMICS;

EID: 35748932024     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.08.043     Document Type: Article

References (24)

1. Andersson K.E., and Yoshida M. Antimuscarinics and the overactive detrusor-which is the main mechanism of action?. Eur Urol 43 (2003) 1
2. Yokoyama O., Yusup A., Miwa Y., Oyama N., Aoki Y., and Akino H. Effects of tolterodine on an overactive bladder depend on suppression of C-fiber bladder afferent activity in rats. J Urol 174 (2005) 2032
3. De Laet K., De Wachter S., and Wyndaele J.J. Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics. Neurourol Urodyn 25 (2006) 156
4. Abrams P., Andersson K.E., Buccafusco J.J., Chapple C., de Groat W.C., Fryer A.D., et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148 (2006) 565
5. Boy S., Schurch B., Mehnert U., Mehring G., Karsenty G., and Reitz A. The effects of tolterodine on bladder filling sensations and perception thresholds towards electrical stimulation-description of the method and initial results. BJU Int 100 (2007) 574
6. De Wachter S., and Wyndaele J.J. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol 169 (2003) 1892
7. Andersson K.E., and Chapple C.R. Oxybutynin and the overactive bladder. World J Urol 19 (2001) 319
8. De Wachter S., and Wyndaele J.J. Can the sensory threshold toward electrical stimulation be used to quantify the subjective perception of bladder filling?. A study in young healthy volunteers. Urology 57 (2001) 655
9. Wyndaele J.J., and De Wachter S. The basics behind bladder pain: a review of data on lower urinary tract sensations. Int J Urol 10 suppl (2003) S49
10. De Wachter S., and Wyndaele J.J. Quest for standardisation of electrical sensory testing in the lower urinary tract: the influence of technique related factors on bladder electrical thresholds. Neurourol Urodyn 22 (2003) 118
11. Wyndaele J.J. Is abnormal electrosensitivity in the lower urinary tract a sign of neuropathy?. Br J Urol 72 (1993) 575
12. Frimodt-Moller C: A new method for quantitative evaluation of bladder sensibility. Scand J Urol Nephrol, suppl., 6: 135.
13. De Wachter S., Van Meel T.D., and Wyndaele J.J. Study of the afferent nervous system and its evaluation in women with impaired detrusor contractility treated with bethanechol. Urology 62 (2003) 54
14. De Wachter S., and Wyndaele J.J. Impact of rectal distention on the results of evaluations of lower urinary tract sensation. J Urol 169 (2003) 1392
15. Olsson B., and Szamosi J. Food does not influence the pharmacokinetics of a new extended release formulation of tolterodine for once daily treatment of patients with overactive bladder. Clin Pharmacokinet 40 (2001) 135
16. Finkel J.C., Yang C.I., Yarvitz J.L., and Patel K.M. Neuroselective sensory electrodiagnostic evaluation of 4% liposomal topical lidocaine. Anesth Analg 94 (2002) 1259
17. Koga K., Furue H., Rashid M.H., Takaki A., Katafuchi T., and Yoshimura M. Selective activation of primary afferent fibers evaluated by sine-wave electrical stimulation. Mol Pain 1 (2005) 13
18. Ukimura O., Ushijima S., Honjo H., Iwata T., Suzuki K., Hirahara N., et al. Neuroselective current perception threshold evaluation of bladder mucosal sensory function. Eur Urol 45 (2004) 70
19. De Laet K., De Wachter S., and Wyndaele J.J. Current perception thresholds in the lower urinary tract: sine- and square-wave currents studied in young healthy volunteers. Neurourol Urodyn 24 (2005) 261
20. de Groat W.C., Booth A.M., and Yoshimura N. Neurophysiology of micturition and its modification in animal models of human disease. In: Maggi C.A. (Ed). The Autonomic Nervous System vol 6 (1993), Harwood Academic Publishers, London, United Kingdom 227-290
21. Silva C., Ribeiro M.J., and Cruz F. The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168 (2002) 575
22. Fowler C.J., Jewkes D., McDonald W.I., Lynn B., and de Groat W.C. Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339 (1992) 1239
23. Yoshida M., Miyamae K., Iwashita H., Otani M., and Inadome A. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63 (2004) 17
24. Yossepowitch O., Gillon G., Baniel J., Engelstein D., and Livne P.M. The effect of cholinergic enhancement during filling cystometry: can edrophonium chloride be used as a provocative test for overactive bladder?. J Urol 165 (2001) 1441